Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Haemophilia A With Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Post-approval studies (Phase 4)Study completedNCT01128881
What this trial is testing

IMMUNINE Pre-Treatment Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 57
Testing effectiveness (Phase 2)Study completedNCT04073498
What this trial is testing

The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)

Who this might be right for
Hemophilia aHemophilia B
ApcinteX Ltd 39
Not applicableStudy completedNCT01051076
What this trial is testing

Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced)

Who this might be right for
Severe Hemophilia A
City of Hope Medical Center 3
Large-scale testing (Phase 3)Looking for participantsNCT05145127
What this trial is testing

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Pfizer 245
Not applicableStudy completedNCT04165135
What this trial is testing

An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment

Who this might be right for
Severe Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHaemophilia A
Hoffmann-La Roche 103
Large-scale testing (Phase 3)Study completedNCT03938792
What this trial is testing

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 188
Early research (Phase 1)Study completedNCT02571569
What this trial is testing

A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 32
Not applicableNot Yet RecruitingNCT07788469
What this trial is testing

Elranatamab for Inhibitor Eradication in Patients With Hemophilia A

Who this might be right for
Hemophilia A With Inhibitors
Institute of Hematology & Blood Diseases Hospital, China 20
Large-scale testing (Phase 3)Study completedNCT03417245
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 120
Large-scale testing (Phase 3)Study completedNCT03417102
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 60
Not applicableUnknownNCT01505946
What this trial is testing

Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With Inhibitors

Who this might be right for
Severe Hemophilia A With Inhibitor
Grifols Italia S.p.A 25
Not applicableStudy completedNCT00166309
What this trial is testing

The FEIBA NovoSeven Comparative Study

Who this might be right for
Severe Hemophilia A With an Inhibitor
Skane University Hospital 60